UPDATE: H.C. Wainwright Downgrades Intercept Pharmaceuticals (ICPT) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Intercept Pharma (ICPT) Misses Q4 EPS by 11c, Revenues Miss
February 25, 2021 7:29 AM ESTIntercept Pharma (NASDAQ: ICPT) reported Q4 EPS of ($1.58), $0.11 worse than the analyst estimate of ($1.47). Revenue for the quarter came in at $83.27 million versus the consensus estimate of $85.01 million.
As we turn the page on 2020, I am proud of the Intercept teams efforts to... More
Intercept Pharma (ICPT) Announces Dagmar Rosa-Bjorkeson to Board
February 23, 2021 8:27 AM ESTIntercept Pharmaceuticals, Inc. (NASDAQ: ICPT) today announced the appointment of Dagmar Rosa-Bjorkeson to its Board of Directors as of April 1, 2021.
Ms. Rosa-Bjorkeson has more than 25 years of global experience in the pharmaceutical industry, including executive leadership positions in corporate and product strategy, market development and operational execution. She is currently the Chief Operating Officer of Mesoblast Limited. Ms. Rosa-Bjorkeson has led... More
Intercept Pharma (ICPT) Chief Medical Officer Jason Campagna Resigns to Pursue Other Opportunities
February 22, 2021 4:53 PM ESTIntercept Pharma (NASDAQ: ICPT) disclosed:
On February 18, 2021, Jason Campagna, M.D., Ph.D., notified Intercept Pharmaceuticals, Inc. (the Company) of his decision to resign from his position as the Companys Chief Medical Officer, effective March 5, 2021, in order to pursue other opportunities. Dr.... More
